AI assistant
Emcure Pharmaceuticals Limited — Call Transcript 2024
Nov 8, 2024
60464_rns_2024-11-08_bcdba81e-7cdb-4923-a896-be5a58b57877.pdf
Call Transcript
Open in viewerOpens in your device viewer
Emcure
Ref: EPL/CS/SE/0026/2024
Date: November 08, 2024
To,
| National Stock Exchange of India LimitedExchange Plaza, C-1, Block G,Bandra Kurla Complex, Bandra (East),Mumbai – 400 051Script Symbol: EMCURE | BSE LimitedP J Towers,Dalal Street,Mumbai - 400 001Scrip Code/Symbol: 544210/ EMCURE |
|---|
Dear Sir/Madam,
Subject: Audio recording of Earnings Call – Q2 FY25
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024 regarding earnings call, the audio recording of the call held yesterday i.e. on November 07, 2024, is available on our website. The said audio recording can be accessed through the below web address:
https://www.emcure.com/wp-content/uploads/2024/11/EMC0220241107156104.mp3
You are requested to take the above information on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
SHARMA Digitally signed by SHARMA CHETAN CHETAN RAJENDRA RAJENDRA Date: 2024.11.08 15:42:38 +05'30'
Chetan Sharma Company Secretary & Compliance Officer Membership Number: F8352
Emcure Pharmaceuticals Limited
Registered Office : Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: [email protected] Website: www.emcure.com CIN: L24231PN1981PLC024251